Earnings Preview: Pfizer to report on 4th quarter

Pfizer Inc., which reports fourth-quarter results before the stock market opens Tuesday, will tout two recent drug approvals, discuss a couple of other drugs awaiting approval and outline its revenue prospects now that it has generic competition to cholesterol blockbuster Lipitor.